Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

. 2016 Feb 18;16:120. doi: 10.1186/s12885-016-2141-4

Table 4.

Multivariate analysis for overall survival

Characteristics HR (95 % CI) p-value
Age (≥65 vs <65) 9.749 (3.404–27.919) <0.001
Sex (female vs male) 3.070 (1.260–7.478) 0.014
T stage (T4 vs T1-3) 3.511 (1.484–8.307) 0.004
Use of Cetuximab at 1st post-operative chemotherapy (Yes vs No) 1.185 (0.235–5.979) 0.837

Abbreviations: CI confidence interval A.A amino acid; HR, hazard ratio

HHS Vulnerability Disclosure